share_log

Form 144 | Olema Pharmaceuticals(OLMA.US)董事拟出售1.5万股股份，价值约14.26万美元

Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 142.65K in Common Stocks

moomoo News ·  Apr 30 15:27

SEC FILLINGS DISCLOSED/ Apr 30, $Olema Pharmaceuticals (OLMA.US)$ Director Harmon Cyrus intends to sell 15,000 shares of its common stock on Apr 30, with a total market value of approximately $142.65K.

Harmon Cyrus has reduced shareholding in $Olema Pharmaceuticals (OLMA.US)$ by 75,000 shares since Jan 31, 2024, with a total value of approximately $913.23K.

1714505277223688950.png

Source: Announcement

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment